Binding Affinity Prediction for Pancreatic Ductal Adenocarcinoma Using Drug-Target Descriptors and Artificial Intelligence
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive form of pancreatic cancer, accounting for 90% of all pancreatic malignancies. This study addresses the gap in disease-specific binding affinity prediction by integrating PDAC-derived targets with diverse molecular descriptors...
Saved in:
| Main Authors: | Pragya, A. Amalin Prince, Jac Fredo Agastinose Ronickom |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IEEE
2025-01-01
|
| Series: | IEEE Access |
| Subjects: | |
| Online Access: | https://ieeexplore.ieee.org/document/11052238/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
by: Iris Pontón, et al.
Published: (2025-07-01) -
Targeted Suppression of CEACAM6 via pHLIP-Delivered RNAs in Pancreatic Ductal Adenocarcinoma
by: Hongsik Kim, et al.
Published: (2025-03-01) -
FingerDTA: A Fingerprint-Embedding Framework for Drug-Target Binding Affinity Prediction
by: Xuekai Zhu, et al.
Published: (2023-03-01) -
Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01) -
Contribution of gut microbiome to pancreatic ductal adenocarcinoma development
by: D. V. Zaitsev, et al.
Published: (2025-05-01)